The Meningococcal Vaccines Market is projected to increase from USD 4.4 billion in 2026 to USD 5.9 billion by 2033, registering a CAGR of 4.5%. After reaching USD 4.1 billion in 2025, the Meningococcal Vaccines Market is entering a period in which growth opportunities vary considerably across vaccine brands, serogroups, age groups, and geographies. Rather than following one uniform...